Thrombolytic Science, LLC
Records under this name other than the patents Thrombolytic Science, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 4 of 4 · Back to Thrombolytic Science, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,837,992 | C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis Formerly held In force Term ended Oct 30, 2026 · From the USPTO record | In force | Term ended Oct 30, 2026 | From the USPTO record |
| US 8,187,592 | C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis Term ended Term ended Jul 9, 2026 · From the USPTO record | Term ended | Term ended Jul 9, 2026 | From the USPTO record |
| US 7,070,958 | Methods of making pro-urokinase mutants Term ended Term ended Jul 13, 2024 · From the USPTO record | Term ended | Term ended Jul 13, 2024 | From the USPTO record |
| US 7,074,401 | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots Term ended Term ended May 25, 2024 · From the USPTO record | Term ended | Term ended May 25, 2024 | From the USPTO record |